Soflaee, Mona Hoseini
Kesavan, Rushendhiran http://orcid.org/0000-0002-8540-8093
Sahu, Umakant
Tasdogan, Alpaslan http://orcid.org/0000-0003-2543-852X
Villa, Elodie
Djabari, Zied
Cai, Feng
Tran, Diem H. http://orcid.org/0000-0003-3612-1464
Vu, Hieu S.
Ali, Eunus S. http://orcid.org/0000-0002-9477-3500
Rion, Halie
O’Hara, Brendan P.
Kelekar, Sherwin
Hallett, James Hughes
Martin, Misty
Mathews, Thomas P.
Gao, Peng http://orcid.org/0000-0002-9991-6064
Asara, John M.
Manning, Brendan D. http://orcid.org/0000-0003-3895-5956
Ben-Sahra, Issam http://orcid.org/0000-0001-9333-4162
Hoxhaj, Gerta http://orcid.org/0000-0001-6179-3583
Article History
Received: 19 January 2022
Accepted: 22 April 2022
First Online: 16 May 2022
Competing interests
: B.D.M. is a shareholder and scientific advisory board member of Navitor Pharmaceuticals. The remaining authors declare no competing interests.